deficiency beta-arrestin signal complex contributes insulin resistance
insulin resistance hallmark type diabetes defect insulin stimulating insulin receptor signalling become one serious public health threats upon stimulation insulin insulin receptor recruits phosphorylates insulin receptor substrate proteins leading activation phosphatidylinositol--oh kinase pi k-akt pathway activated akt phosphorylates downstream kinases transcription factors thus mediating metabolic actions insulin- beta-arrestins mediate biological functions g-protein-coupled receptors linking activated receptors distinct sets accessory effecter proteins thereby determining specificity efficiency capacity signals- show diabetic mouse models beta-arrestin severely downregulated knockdown beta-arrestin exacerbates insulin resistance whereas administration beta-arrestin restores insulin sensitivity mice investigation reveals insulin stimulates formation new beta-arrestin signal complex beta-arrestin scaffolds akt src insulin receptor loss dysfunction beta-arrestin results deficiency signal complex disturbance insulin signalling vivo thereby contributing development insulin resistance progression type diabetes findings provide new insight molecular pathogenesis insulin resistance implicate new preventive therapeutic strategies insulin resistance type diabetes
